GlaxoSmithKline - Top 10 Layoffs of 2010

Company: GlaxoSmithKline
Layoffs: 5,201

Scoop: CEO Andrew Witty spent the year finding cost-saving options for the company, including laying off workers in Europe and the U.S., including 700 from the sales and marketing division. GSK believes the future is in emerging markets, particularly in Asia and South America, and its transferring much of its muster into those areas with numerous deals.

But beyond layoffs, Witty looked at other failing strategies, including spending £3 billion in nine years on research that found no new products.

GlaxoSmithKline - Top 10 Layoffs of 2010
Read more on

Suggested Articles

Trump has said the coronavirus outbreak doesn't pose a major threat to the U.S., but the White House is weighing naming a "czar," Politico…

After a major label expansion in December, Amarin's Vascepa is preparing a major boom in sales with its marketing team nearly scaled up.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.